Literature DB >> 20417082

Predictors of mortality in COPD.

Bartolome R Celli1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in adults. Although FEV(1) remains the most important physiologic indicator of the severity of airflow obstruction in COPD, its predictive value for mortality is weak when it is higher than 50% of predicted. Furthermore, other easily obtainable clinical variables predict mortality better than the FEV(1) in COPD patients with a wide range of airflow limitation. Chief among these predictors are functional dyspnea, exercise capacity, and the body mass index (BMI), although emerging research suggests a potential role for biomarker profiles in outcome predictions. The validated multidimensional BMI (B), degree of airflow obstruction as expressed by the FEV(1) (O), dyspnea with the modified medical research council (D), and exercise (E) measured with the 6min walk or BODE index encompasses the predictive validity of the best of these variables into a single surrogate measure of disease severity and survival. This article reviews these predictors of mortality in COPD. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417082     DOI: 10.1016/j.rmed.2009.12.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  59 in total

1.  The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.

Authors:  Su-Jung Chen; Chiu-Mei Yeh; Tze-Fan Chao; Chia-Jen Liu; Kang-Ling Wang; Tzeng-Ji Chen; Pesus Chou; Fu-Der Wang
Journal:  Sleep       Date:  2015-07-01       Impact factor: 5.849

2.  Mortality in Spain in the Context of the Economic Crisis and Austerity Policies.

Authors:  Enrique Regidor; Alberto Mateo; Gregorio Barrio; Luis de la Fuente
Journal:  Am J Public Health       Date:  2019-05-16       Impact factor: 9.308

Review 3.  Indications for lung transplant referral and listing.

Authors:  Omar Shweish; Goutham Dronavalli
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 4.  Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions.

Authors:  Faisal M Siddiqui; Joshua M Diamond
Journal:  Curr Opin Pulm Med       Date:  2018-03       Impact factor: 3.155

5.  Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD.

Authors:  Leila Donária; Rafael Mesquita; Larissa Martinez; Luciana Sípoli; Josiane Marques Felcar; Vanessa Suziane Probst; Nidia Aparecida Hernandes; Fabio Pitta
Journal:  Lung       Date:  2014-10-01       Impact factor: 2.584

6.  Obesity and extent of emphysema depicted at CT.

Authors:  S Gu; R Li; J K Leader; B Zheng; J Bon; D Gur; F Sciurba; C Jin; J Pu
Journal:  Clin Radiol       Date:  2015-02-19       Impact factor: 2.350

Review 7.  Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments.

Authors:  Luigi Santambrogio; Paolo Tarsia; Paolo Mendogni; Davide Tosi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

8.  Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.

Authors:  Chan Joo Yang; Jong-Lyel Roh; Min-Ju Kim; Sang-wook Lee; Sung-Bae Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Qual Life Res       Date:  2015-07-09       Impact factor: 4.147

9.  Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitation.

Authors:  Esther Dajczman; Rima Wardini; Goulnar Kasymjanova; David Préfontaine; Marc Alexander Baltzan; Norman Wolkove
Journal:  Can Respir J       Date:  2015 Jul-Aug       Impact factor: 2.409

10.  Diagnosis of chronic obstructive pulmonary disease in the primary care setting.

Authors:  D Spyratos; D Chloros; L Sichletidis
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.